FDA publishes heart risk of Pfizer Covid shots: “increased risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination”-FDA.gov, 7/23/21

7/23/21, “Pfizer-BioNTech COVID-19 Vaccine," FDA.gov

“On June 25, 2021, the FDA revised the patient and provider fact sheets regarding the suggested increased risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination. The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S.”

 

.............